Management of Adrenal Adenoma
All patients with an adrenal adenoma ≥1 cm require comprehensive biochemical testing to exclude hormone excess and imaging characterization to assess malignancy risk, with surgical resection indicated for any hormonally active lesion, masses ≥4 cm with concerning features, or growth >5 mm/year. 1, 2
Initial Evaluation Framework
Biochemical Testing (Mandatory for All Adenomas)
Every adrenal adenoma requires screening for three critical hormone excesses 1:
Cortisol excess: 1-mg overnight dexamethasone suppression test
- Cortisol >5.0 mg/dL indicates subclinical Cushing syndrome (SCS)
- Add low ACTH or low DHEA-S to confirm diagnosis
- Consider second confirmatory test (2-day low-dose dexamethasone suppression test) 1
Aldosterone excess (if hypertensive): Plasma aldosterone-to-renin ratio (PAC/PRA)
- Ratio >20 requires confirmatory salt loading test
- Proceed to adrenal venous sampling in patients >40 years to lateralize 1
Pheochromocytoma: Plasma fractionated metanephrines and normetanephrines OR 24-hour urinary metanephrines
- Critical: Must exclude pheochromocytoma before ANY adrenal surgery 1
Imaging Characterization
Non-contrast CT (NCCT) is the first-line imaging study 2:
- ≤10 HU: Benign lipid-rich adenoma—no further imaging needed regardless of size 2, 1
- 11-20 HU: Indeterminate—requires additional imaging (adrenal protocol CT with washout, MRI with chemical shift, or PET-CT) 2
- >20 HU: Suspicious—multidisciplinary discussion for surgery vs. close follow-up 2
Size thresholds matter 2:
- <4 cm with benign features: Lower malignancy risk (0.5%)
- 4-6 cm: 6% malignancy risk
6 cm: >25% malignancy risk
Surgical Indications (Definitive)
Proceed with laparoscopic adrenalectomy for 1, 3:
Any hormonally active adenoma:
Size/imaging criteria:
Growth on surveillance:
Use open adrenalectomy if adrenocortical carcinoma suspected 1
Non-Surgical Management (Surveillance Protocol)
For benign-appearing, non-functional adenomas <4 cm 1, 2, 1:
Imaging follow-up:
- Repeat imaging at 6-12 months (NCCT or MRI preferred) 2
- If stable, no further imaging needed after 12 months of stability 2
- Exception: Older guidelines 1 suggested annual imaging for 1-2 years, but 2025 ESE guidelines 2 indicate single follow-up at 12 months is sufficient
Biochemical follow-up:
- Annual hormonal testing for up to 5 years 1
- Risk of developing hormone excess: 17% at 1 year, 29% at 2 years, 47% at 5 years 1
For indeterminate lesions (remain unclear after additional imaging) 2:
- Multidisciplinary discussion required
- Options: Surgical resection vs. repeat imaging in 6-12 months
- Surgery strongly favored if patient <40 years old (higher malignancy risk) 2
Special Populations
Patients <40 years, pregnant, or children 2:
- Urgent assessment required (higher malignancy risk)
- MRI preferred over CT to avoid radiation
- Consider surgery for any lesion not characteristically benign
- Even benign-appearing lesions warrant single follow-up at 12 months
Patients with extra-adrenal malignancy 2:
- Up to 70% of indeterminate lesions are malignant in this population
- Still exclude pheochromocytoma biochemically before biopsy
- Biopsy only if histologic diagnosis would alter management
Critical Perioperative Considerations
For cortisol-producing adenomas 1:
- Perioperative glucocorticoid coverage mandatory
- Continue replacement 6-18 months post-adrenalectomy until HPA axis recovers
- Test recovery with morning cortisol or cosyntropin stimulation 3
- α-blockade for 1-3 weeks preoperatively (selective or non-selective)
- Long-term follow-up required: 10-15% recurrence rate 1
For primary aldosteronism 1:
- If bilateral hyperplasia or patient refuses surgery: mineralocorticoid receptor blockers (spironolactone or eplerenone)
Common Pitfalls to Avoid
Never attempt adrenal surgery without excluding pheochromocytoma—can cause fatal intraoperative hypertensive crisis 1
Don't assume large size alone = malignancy—most adenomas >4 cm are benign if HU ≤10 2, 6
Don't skip biochemical testing even if imaging appears benign—27.5% of incidentalomas are functional 4, 7
Don't use laparoscopic approach if adrenocortical carcinoma suspected—requires open en bloc resection at high-volume center 1, 3
Don't forget glucocorticoid replacement after resecting cortisol-producing adenomas—adrenal insufficiency can be life-threatening 1